Please assess the completion status of the following clinical trial:

Trial Title: Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Primary diagnosis ADHD~* Total score of greater than or equal to 26 on ADHD-RS-IV~* IQ of greater than or equal to 80~* Blood pressure measurements within 95th percentile for age, gender, height at screening and baseline~Exclusion Criteria:~* Current controlled (requiring a restricted medication) or uncontrolled, comorbid psychiatric diagnosis (except ODD)~* Known nonresponder to psychostimulant treatment~* BMI for age greater than 90th percentile~* History of seizures during last 2 years~* Conduct Disorder

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Methylphenidate Transdermal System (Type: ACTIVE_COMPARATOR): Transdermal patch, 27.5mg, 41.3mg, 55mg, and 82.5mg, daily for 11 weeks
- Placebo (Type: PLACEBO_COMPARATOR): Transdermal patch, 0mg, daily for 11 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).